John Murphy is currently the head of Discovery Biology for Rare Disease Research at Pfizer. In this role he is responsible for all Rare Disease early discovery efforts, which includes projects on rare genetic diseases in  the areas of haematology, neuromuscular, metabolic and cardiology. Dr. Murphy is a molecular biologist by training, having done a…Read more

Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and medical affairs. Chief Medical Officer for ASC Therapeutics, formerly for Symvivo, Myriad Genetics-Crescendo and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira). Senior medical leader experienced in matrixed, line management and consulting…Read more

Rob has been involved in AAV research for over 30 years starting as post-doctoral fellow where he discovered a common integration site on human chromosome 19, AAVS1. During a 20 year career as head of the Gene Therapy and Molecular Virology lab at the National Institutes of Health, Rob continued both basic AAV research and…Read more